Clinical Trials Directory

Trials / Completed

CompletedNCT02402621

Comparison Between Conventional and Model-based Infusion Strategy of IV PCA in Patients Undergoing RALP

Comparison Between Conventional and Model-based Infusion Strategy of Intravenous Patient-controlled Analgesia in Patients Undergoing Robot Assisted Laparoscopic Radical Prostatectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
111 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
Male
Age
20 Years – 69 Years
Healthy volunteers
Not accepted

Summary

Comparing postoperative analgesics requirements and complications between conventional and model-based infusion strategy of intravenous patient-controlled analgesia in patients who undergoing robot assisted laparoscopic radical prostatectomy Group A: conventional intravenous patient-controlled analgesia, Group B: model-based infusion strategy of intravenous patient-controlled analgesia

Detailed description

The investigators compared postoperative analgesics requirements and complications between conventional and model-based infusion strategy of intravenous patient-controlled analgesia (IV PCA) in patients who undergoing robot assisted laparoscopic radical prostatectomy (RALP) Group A: conventional IV PCA, Group B: model based IV PCA 1. Primary endpoint: comparison of postoperative analgesic requirements in patient undergoing robot assisted laparoscopic radical prostatectomy (RALP) between conventional patient controlled analgesia (PCA) (Group A) and effective-compartment based dosing strategy of PCA (Group B) 2. Secondary endpoint: 1) VAS analysis between two groups, 2) postoperative nausea and vomiting analysis between two groups, 3) complication evaluation between two groups

Conditions

Interventions

TypeNameDescription
DRUGfentanylfentanyl with antiemetic drug

Timeline

Start date
2015-04-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2015-03-30
Last updated
2015-12-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02402621. Inclusion in this directory is not an endorsement.